Sleep isn't a consolation prize. It's a pathway to recovery.
Long after the visible battles of cancer treatment end, millions of survivors face a quieter struggle in the dark — persistent insomnia that erodes recovery, mood, and quality of life, yet goes largely untreated. Dr. Sheila Garland, a psychologist and oncology researcher at Memorial University, has spent a decade confronting this gap, and her answer is iCANSleep, a free smartphone app that brings evidence-based cognitive behavioural therapy directly to survivors who cannot reach specialists. Her work has now earned her the William E. Rawls Prize from the Canadian Cancer Society — a recognition that the suffering which follows a cancer diagnosis does not end with the final treatment, and that the tools to address it must travel as far as the people who need them.
- Six in ten cancer survivors experience serious sleep disturbances — four to five times the general population rate — yet fewer than one in five ever receive treatment, exposing a vast and largely invisible crisis in survivorship care.
- Specialists are scarce, waitlists stretch for months, and many survivors are too ill or too remote to travel, leaving an evidence-based treatment sitting out of reach for the people who need it most.
- Dr. Garland built iCANSleep to cross that distance — a free app delivering cognitive behavioural therapy for insomnia directly to survivors in rural communities, immunocompromised patients, and anyone the current system has failed to reach.
- The William E. Rawls Prize, carrying $20,000 in funding, now gives her team the resources to rigorously test the platform and push toward nationwide implementation.
- The award signals something larger than personal recognition — it affirms that psychosocial oncology and the post-treatment lives of survivors deserve serious scientific investment and systemic attention.
Most people assume cancer treatment ends with the last chemotherapy session or the final radiation appointment. For the majority of survivors, however, a quieter struggle persists — one that unfolds night after night, when sleep refuses to come.
Dr. Sheila Garland, a psychologist and oncology researcher at Memorial University, has spent a decade mapping this aftermath. Her findings are striking: roughly six in ten people diagnosed with cancer experience serious sleep disturbances, a rate four to five times higher than the general population. Yet fewer than one in five survivors ever receive treatment for it. The gap between need and access is enormous.
Garland's response was to build a bridge using technology. iCANSleep is a free smartphone application that guides cancer survivors through cognitive behavioural therapy for insomnia — a proven treatment that most survivors never reach because specialists are scarce, appointments take months, and many patients are too remote or immunocompromised to travel. The app brings the therapy directly to them. A clinical trial of the platform, funded by a Canadian Cancer Society Emerging Scholar Award, is currently underway.
That work has now earned her the William E. Rawls Prize, a national honour for early-career researchers making outstanding contributions to cancer control. The accompanying $20,000 will allow her team to continue developing and testing iCANSleep with the rigour the science demands.
For Garland, sleep is not a luxury — it is a genuine mechanism of recovery, shaping mood, cognition, immune function, and quality of life. When it breaks, everything downstream breaks with it. The prize, she understands, is more than personal recognition. It affirms that the mental and physical health of survivors matters, signals to her students and to the field that this work is valued, and provides the resources to keep moving toward a future where no cancer survivor has to lie awake without access to effective help — regardless of who they are or where they live.
Most people think of cancer treatment as ending when the last round of chemotherapy finishes or the final radiation appointment passes. But for the majority of survivors, the struggle continues long after the visible battle is over—and it happens in the dark, night after night, when sleep won't come.
Dr. Sheila Garland, a psychologist and oncology researcher at Memorial University, has spent the last decade studying this particular aftermath. She discovered something that should alarm anyone who works in cancer care: roughly six out of every ten people diagnosed with cancer experience serious sleep disturbances. That's four to five times the rate seen in the general population. Yet despite how common the problem is, fewer than one in five cancer survivors ever receive actual treatment for it. The gap between need and access is enormous.
Garland's response has been to build a bridge across that gap using technology. She created iCANSleep, a free smartphone application that walks cancer survivors through cognitive behavioural therapy for insomnia—a treatment method that works, but one that most survivors never reach because specialists are scarce, appointments take months to secure, and many patients live too far away or are too immunocompromised to travel. The app brings the therapy to them, wherever they are. She is currently running a clinical trial of the platform, funded by a Canadian Cancer Society Emerging Scholar Award in Cancer Survivorship.
This work has now earned her the William E. Rawls Prize, a national honour given by the Canadian Cancer Society to early-career researchers making outstanding contributions to cancer control. The award comes with twenty thousand dollars in funding—money that will allow her team to continue developing and testing iCANSleep with the rigour the work demands.
Garland speaks about sleep not as a luxury or a consolation, but as a genuine mechanism of recovery. Sleep shapes mood, cognition, immune function, and quality of life. When it's broken, everything downstream breaks too. The problem is not that survivors don't know this; it's that the system hasn't caught up. Treatment for insomnia exists and it works, but it remains largely inaccessible to the people who need it most—those in rural areas, those who are immunocompromised, those who cannot afford to wait months for a specialist appointment.
For Garland, the prize represents more than personal recognition. It affirms that the mental and physical health of cancer survivors matters, and that the science of addressing it deserves investment and attention. It signals to her team, to her graduate students, and to the field of psychosocial oncology that this work is valued. And it provides the resources to keep moving toward something that could genuinely reshape how sleep care reaches survivors across the country.
Her vision is straightforward and ambitious: a future where no cancer survivor has to lie awake night after night without access to effective help. Where treatment is available regardless of who you are or where you live. The app is one tool toward that end, but it's a tool built on a decade of research and grounded in evidence. What happens next depends on whether the system is ready to listen.
Citações Notáveis
Sleep affects everything: mood, cognition, immune function and quality of life. Fixing sleep isn't a consolation prize at the end of cancer treatment. It's a genuine pathway to recovery.— Dr. Sheila Garland
My research is focused on closing that gap through digital delivery, reaching survivors in rural and remote communities, people who are immunocompromised and can't travel, and those who simply cannot wait months for an appointment.— Dr. Sheila Garland
A Conversa do Hearth Outra perspectiva sobre a história
Why does sleep matter so much in cancer recovery? Isn't the main thing just that the cancer is gone?
Sleep isn't separate from recovery—it's foundational to it. When you sleep poorly, your immune system weakens, your mood deteriorates, your ability to think clearly suffers. For cancer survivors, all of those things directly affect how well they heal and how well they live afterward.
But six out of ten people with cancer have sleep problems. That's a huge number. Why isn't this already being treated?
Because the system isn't built for it. Cognitive behavioural therapy for insomnia works—the evidence is clear—but there aren't enough specialists to deliver it. A patient might wait months for an appointment. If they live in a rural area or can't travel because they're immunocompromised, they might never see a specialist at all.
So the app is meant to replace the specialist?
Not replace. Democratize. The app delivers the same evidence-based therapy, but it reaches people where they are. It removes the barriers of geography, time, and access that keep most survivors from getting help.
What does the prize money actually do?
It lets the research continue with real rigour. It pays for the clinical trial, for graduate students and research staff, for the work of testing whether this actually works at scale. Without it, the idea stays an idea.
What's the end goal here?
A world where a cancer survivor in Newfoundland or rural Alberta can access the same quality sleep treatment as someone in Toronto. Where treatment is available to everyone, not just those who can afford to wait or travel.